Skip to main content
. Author manuscript; available in PMC: 2009 Jul 16.
Published in final edited form as: Curr Mol Pharmacol. 2009 Jun 1;2(2):161–168. doi: 10.2174/1874467210902020161

Fig. 1. Targets for angiogenic inhibition.

Fig. 1

Potential targets of angiogenesis inhibition. Interactions between the tumor cell, its secreted growth factors, and extracellular matrix are all potential targets for angiogenesis inhibition. Figure adapted from Figg et. al. (Ref. 24 Figg, W. D.; Kruger, E. A.; Price, D. K.; Kim, S.; Dahut, W. D. Inhibition of angiogenesis: treatment options for patients with metastatic prostate cancer. Invest. New Drugs 2002, 20, 183–194.)